Abstract
It is the first time so far as I can see that we have the Ca agonists included in a meeting and from that you can conclude that beyond the Ca antagonists some new results are coming along with this exciting type of new drugs. Discussing Ca agonistic drugs opens the window for new indications — even those not covered by present drugs. Let us hope that we go for a developement of Ca agonistic drugs in a few years as intensively as we did and still do with the Ca antagonists.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Krebs, R. (1985). Welcome. In: Fleckenstein, A., Van Breemen, C., Gross, R., Hoffmeister, F. (eds) Cardiovascular Effects of Dihydropyridine-Type Calcium Antagonists and Agonists. Bayer-Symposium, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70499-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-70499-4_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70501-4
Online ISBN: 978-3-642-70499-4
eBook Packages: Springer Book Archive